Fundraising FoxPanache Ventures — 2026 Investments
5 investments dated 2026 · listed companies and verified rows first · show all
biossil is an AI-native biopharma company developing late-stage drug programs for life-threatening conditions with unmet needs, including sickle cell disease, idiopathic pulmonary fibrosis, glioblastoma, breast cancer, and Alzheimer's disease.
AI & Machine LearningBiotechHealthtechToronto, CA
Alexander I. Mosa(MD PhD)Anthony Mouchantaf(JD MBA)
Co-investorsFounders FundGolden VenturesStaircase Ventures137 VenturesDRI HealthcareQuiet Capital
Serverless provides the Serverless Framework, an open-source tool for developing, deploying, and monitoring APIs, scheduled tasks, workflows, and event-driven applications on AWS Lambda.
Cloud ComputingDeveloper ToolsSaaS
Austen Collins(Founder)in
Co-investorsHeavybitLightspeed Venture PartnersTrinity VenturesAccelAirbus VenturesAMD Ventures+10 more
.jpeg)
Soma is an insurance brokerage that provides industry-specific business coverage through a single application, working with hundreds of carrier partners.
FintechInsurTech
Co-investorsAccelOverlook VenturesCategory VenturesHaystackRRE VenturesTO VC+1 more
Soma operates an energy intelligence platform that connects power generation, battery storage, and large energy loads such as data centers into a real-time coordination layer to optimize and deliver power.
AI & Machine LearningCleantechEnergyRio de Janeiro, BR
Mario Souto(Founder)inAthanasios Caramanolis(Chief Executive Officer)in
Co-investorsCategory VenturesRRE VenturesUncork CapitalHaystackTO VC
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.